BioXcel Therapeutics (BX2.F) Q2 2024 Earnings

May 9Confirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.81
-0.75
-0.69
-0.63

Details

Expected EPS
-0.625804368
Actual EPS
-0.806664
Surprise EPS
-0.18
Surprise Percent
-28.9%

Description

⁨BioXcel Therapeutics⁩ (⁦BX2.F⁩) has reported earnings of ⁦-0.806664⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts